Pulmatrix Inc., of Lexington, Mass., entered a securities purchase agreement with certain institutional investors, providing for the purchase and sale of about 1.7 million shares of common stock at a price of about $1.46 per share in a registered direct offering priced at the market, resulting in total gross proceeds of about $2.5 million.